tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

SS Innovations Completes Key Study for FDA Submission

Story Highlights
SS Innovations Completes Key Study for FDA Submission

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

SS Innovations International ( (SSII) ) has shared an announcement.

SS Innovations International announced the successful completion of a human factors validation study for its SSi Mantra surgical robotic system at Johns Hopkins Hospital in September 2025. This milestone is crucial for their anticipated 510(k) premarket notification submission to the FDA in the fourth quarter of 2025, which could potentially allow the SSi Mantra to be marketed in the U.S. by the first half of 2026. The company has installed 125 SSi Mantra systems across six countries, with over 6,000 surgical procedures performed, highlighting its growing global footprint.

The most recent analyst rating on (SSII) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on SS Innovations International stock, see the SSII Stock Forecast page.

Spark’s Take on SSII Stock

According to Spark, TipRanks’ AI Analyst, SSII is a Neutral.

SS Innovations International’s stock score is primarily impacted by its financial performance challenges, including negative profitability and cash flow issues. The technical analysis suggests a bearish trend, and the valuation is unattractive due to a negative P/E ratio. These factors collectively result in a low overall stock score.

To see Spark’s full report on SSII stock, click here.

More about SS Innovations International

SS Innovations International, Inc. is a developer of innovative surgical robotic technologies aimed at making robotic surgery affordable and accessible globally. The company’s product offerings include the SSi Mantra surgical robotic system and SSi Mudra surgical instruments, supporting various procedures including robotic cardiac surgery. Headquartered in India, SS Innovations seeks to expand its presence with cost-effective and advanced surgical solutions.

Average Trading Volume: 82,274

Technical Sentiment Signal: Buy

Current Market Cap: $1.37B

For a thorough assessment of SSII stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1